2/23
12:14 pm
okyo
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 [Yahoo! Finance]
Low
Report
OKYO Pharma to present first-in-human urcosimod data at ARVO 2026 [Yahoo! Finance]
2/23
11:00 am
okyo
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
Low
Report
OKYO Abstract Selected for Presentation at Premier Global Ophthalmology Congress
2/21
06:31 am
okyo
OKYO Pharma (NASDAQ:OKYO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
Low
Report
OKYO Pharma (NASDAQ:OKYO) was upgraded by analysts at Piper Sandler to a "strong-buy" rating.
2/20
06:07 am
okyo
OKYO Pharma (NASDAQ:OKYO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
Medium
Report
OKYO Pharma (NASDAQ:OKYO) is now covered by analysts at Piper Sandler. They set an "overweight" rating on the stock.
2/17
01:25 pm
okyo
OKYO Pharma has analysts bullish as FDA endorses Phase 2b/3 trial in neuropathic corneal pain [Yahoo! Finance]
Low
Report
OKYO Pharma has analysts bullish as FDA endorses Phase 2b/3 trial in neuropathic corneal pain [Yahoo! Finance]
2/13
02:17 am
okyo
OKYO Pharma prices public offering at $1.85/share to raise up to $20M [Seeking Alpha]
Medium
Report
OKYO Pharma prices public offering at $1.85/share to raise up to $20M [Seeking Alpha]
2/12
10:20 pm
okyo
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
Medium
Report
OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares
2/12
09:56 pm
okyo
OKYO Pharma appoints Leerink Partners as sales agent for ATM equity offering [Yahoo! Finance]
Medium
Report
OKYO Pharma appoints Leerink Partners as sales agent for ATM equity offering [Yahoo! Finance]
2/12
04:01 pm
okyo
OKYO Pharma Announces Public Offering of Ordinary Shares
Medium
Report
OKYO Pharma Announces Public Offering of Ordinary Shares
2/11
10:09 am
okyo
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
Medium
Report
OKYO Pharma Announces Transition of At-The-Market Equity Offering Facility to Leerink Partners
2/10
09:55 am
okyo
OKYO Pharma appoints Flavio Mantelli as chief medical officer [Yahoo! Finance]
Low
Report
OKYO Pharma appoints Flavio Mantelli as chief medical officer [Yahoo! Finance]
2/10
08:00 am
okyo
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
Low
Report
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
1/30
02:15 pm
okyo
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting [Yahoo! Finance]
Low
Report
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting [Yahoo! Finance]
1/30
11:30 am
okyo
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
Low
Report
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
1/29
10:05 am
okyo
OKYO Pharma (NASDAQ:OKYO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
Low
Report
OKYO Pharma (NASDAQ:OKYO) had its "buy" rating reaffirmed by analysts at HC Wainwright.
1/28
07:40 am
okyo
OKYO Pharma Announces Successful Type C Meeting with the FDA
Medium
Report
OKYO Pharma Announces Successful Type C Meeting with the FDA
1/23
07:00 am
okyo
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
High
Report
FDA Approves Compassionate Use of Urcosimod (0.05%) for the Treatment of Neuropathic Corneal Pain
1/6
06:52 am
okyo
OKYO Pharma Limited's (NASDAQ:OKYO) Intrinsic Value Is Potentially 90% Above Its Share Price [Yahoo! Finance]
High
Report
OKYO Pharma Limited's (NASDAQ:OKYO) Intrinsic Value Is Potentially 90% Above Its Share Price [Yahoo! Finance]
1/5
07:13 am
okyo
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer [Yahoo! Finance]
Medium
Report
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer [Yahoo! Finance]
1/5
07:00 am
okyo
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
High
Report
OKYO Pharma Appoints Industry Veteran Robert J. Dempsey as Chief Executive Officer
12/19
07:49 am
okyo
OKYO Pharma to Ring the Opening Bell at Nasdaq [Yahoo! Finance]
Low
Report
OKYO Pharma to Ring the Opening Bell at Nasdaq [Yahoo! Finance]
12/19
07:00 am
okyo
OKYO Pharma to Ring the Opening Bell at Nasdaq
High
Report
OKYO Pharma to Ring the Opening Bell at Nasdaq
12/15
08:30 am
okyo
OKYO Pharma Announces Chairman and Founder Acquires Shares
Medium
Report
OKYO Pharma Announces Chairman and Founder Acquires Shares
12/11
09:13 am
okyo
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain [Yahoo! Finance]
Medium
Report
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain [Yahoo! Finance]
12/11
08:30 am
okyo
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
Low
Report
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain